Tempus AI (NASDAQ:TEM) Sees Large Volume Increase - Still a Buy?

Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 3,894,953 shares traded hands during mid-day trading, a decline of 24% from the previous session's volume of 5,108,802 shares.The stock last traded at $59.27 and had previously closed at $59.00.

Analyst Ratings Changes

A number of research firms recently weighed in on TEM. Loop Capital decreased their target price on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research report on Tuesday, January 14th. Wolfe Research lowered Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Bank of America boosted their price target on Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. William Blair reissued a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and a consensus price target of $61.18.

Tempus AI Stock Down 9.1 %

The firm's 50 day simple moving average is $57.78 and its two-hundred day simple moving average is $51.47. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Remove Ads

Insiders Place Their Bets

In other Tempus AI news, Director Jennifer A. Doudna sold 1,320 shares of the firm's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $90.00, for a total value of $118,800.00. Following the sale, the director now owns 36,011 shares of the company's stock, valued at approximately $3,240,990. This trade represents a 3.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Bradley A. Keywell sold 170,720 shares of the business's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $35.45, for a total value of $6,052,024.00. Following the transaction, the insider now directly owns 15,993,729 shares of the company's stock, valued at $566,977,693.05. This trade represents a 1.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 5,598,969 shares of company stock worth $317,194,162 in the last 90 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of TEM. First Horizon Advisors Inc. acquired a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $30,000. Operose Advisors LLC bought a new position in Tempus AI in the 4th quarter valued at approximately $25,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC boosted its holdings in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after acquiring an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC bought a new stake in Tempus AI during the 4th quarter worth $49,000. Institutional investors own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.